7.71
Schlusskurs vom Vortag:
$7.72
Offen:
$7.47
24-Stunden-Volumen:
117.80K
Relative Volume:
0.73
Marktkapitalisierung:
$288.59M
Einnahmen:
$4.71M
Nettoeinkommen (Verlust:
$-46.77M
KGV:
-4.5915
EPS:
-1.6792
Netto-Cashflow:
$-60.34M
1W Leistung:
-1.15%
1M Leistung:
+18.80%
6M Leistung:
+2.39%
1J Leistung:
-17.27%
Nyxoah Sa Stock (NYXH) Company Profile
Vergleichen Sie NYXH mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
NYXH
Nyxoah Sa
|
7.71 | 291.95M | 4.71M | -46.77M | -60.34M | -1.6792 |
![]()
ISRG
Intuitive Surgical Inc
|
558.06 | 199.19B | 8.71B | 2.48B | 1.75B | 6.82 |
![]()
BDX
Becton Dickinson Co
|
171.03 | 49.82B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
ALC
Alcon Inc
|
86.93 | 42.71B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
RMD
Resmed Inc
|
249.69 | 35.94B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
WST
West Pharmaceutical Services Inc
|
218.58 | 15.12B | 2.90B | 467.20M | 306.90M | 6.37 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2023-07-31 | Eingeleitet | H.C. Wainwright | Buy |
2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
2022-04-21 | Eingeleitet | Oppenheimer | Outperform |
2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
2021-12-21 | Fortgesetzt | Cantor Fitzgerald | Overweight |
2021-07-28 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Nyxoah Sa Aktie (NYXH) Neueste Nachrichten
Top Premarket Decliners - marketscreener.com
Millennium Management LLC Trims Stock Holdings in Nyxoah S.A. (NASDAQ:NYXH) - Defense World
Nyxoah Announces Change in Shareholder Voting Rights - TipRanks
Publication relating to transparency notifications - Yahoo Finance
Nyxoah to Present at the Jefferies Global Healthcare Conference - The Manila Times
Nyxoah CEO Showcases Revolutionary Sleep Apnea Treatment at Major Jefferies Healthcare Conference - Stock Titan
Nyxoah SA Updates Share Capital and Voting Rights - TipRanks
Information on the total number of voting rights and shares - Yahoo
Head-To-Head Survey: Inspire Medical Systems (NYSE:INSP) versus Nyxoah (NASDAQ:NYXH) - Defense World
Cantor maintains Nyxoah stock Overweight with $14 target By Investing.com - Investing.com Nigeria
Nyxoah Announces CE Mark Approval For Genio® 2.1 - Barchart.com
Cantor maintains Nyxoah stock Overweight with $14 target - Investing.com
Nyxoah SA (NYXH) Reports Q1 Loss, Lags Revenue Estimates - MSN
Trading (NYXH) With Integrated Risk Controls - news.stocktradersdaily.com
Nyxoah Sa’s Earnings Call: Progress Amid Challenges - TipRanks
Nyxoah outlines U.S. Genio launch plan with 50-member team as FDA approval expected Q2 2025 - MSN
Nyxoah S.A. (NASDAQ:NYXH) Q1 2025 Earnings Call Transcript - Insider Monkey
Nyxoah Reports Q1 2025 Financial Results and FDA Progress - TipRanks
Nyxoah Q1 2025 Earnings Call Transcript - MarketBeat
Nyxoah Nears FDA Approval for Genio® System Amid Q1 2025 Results - TipRanks
Nyxoah (NYXH) Nears FDA Approval for Genio System in the U.S. | - GuruFocus
Nyxoah reports Q1 EPS (EUR 0.60) vs. (EUR 0.42) last year - TipRanks
Nyxoah Nears FDA Approval for Sleep Apnea Device as Q1 Revenue Hits €1.1M | NYXH Stock News - Stock Titan
Nyxoah Reports First Quarter Financial and Operating Results - The Manila Times
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Nyxoah S.A. – NYXH - Bluefield Daily Telegraph
Earnings To Watch: Nyxoah SA (NYXH) Reports Q1 2025 Result - GuruFocus
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A.NYXH - PR Newswire
Nyxoah (NYXH) Expected to Announce Quarterly Earnings on Tuesday - Defense World
Nyxoah SA Schedules Shareholders’ Meetings for June 2025 - TipRanks
Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 11, 2025 - Yahoo Finance
Nyxoah to Release First Quarter 2025 Financial Results on May 14, 2025 - The Manila Times
REG-Nyxoah to Release First Quarter 2025 Financial Results on May 14, 2025 - TradingView
Renaissance Technologies LLC Purchases Shares of 23,400 Nyxoah S.A. (NASDAQ:NYXH) - Defense World
Long Term Trading Analysis for (NYXH) - news.stocktradersdaily.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Nyxoah S.A.NYXH - Bluefield Daily Telegraph
Nyxoah S.A. (NASDAQ:NYXH) Shares Bought by Geode Capital Management LLC - Defense World
LPL Financial LLC Buys Shares of 12,700 Nyxoah S.A. (NASDAQ:NYXH) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Stifel cuts Nyxoah stock price target to $14, maintains Buy rating - Investing.com Canada
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OSI Systems, Inc. - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Shareholders to Learn More About the Investigation - markets.businessinsider.com
Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - markets.businessinsider.com
Finanzdaten der Nyxoah Sa-Aktie (NYXH)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):